HPV DNA detection by in situ hybridization with catalyzed signal amplification on thin-layer cervical smears

Journal of Histochemistry and Cytochemistry

Volumn 50, Issue 10, 2002, Pages 1417-1420

  Samama, Brigitte ^a   Plas Roser, Salomé ^a   Schaeffer, Christiane ^a   Chateau, Danielle ^a   Fabre, Michel ^a   Boehm, Nelly ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Cervical smears; Human papilloma virus; In situ hybridization; Thin layer cytology; Tyramide amplification

Indexed keywords

VIRUS DNA;

ARTICLE; CONTROLLED STUDY; GENE AMPLIFICATION; HUMAN; IN SITU HYBRIDIZATION; NONHUMAN; PAPANICOLAOU TEST; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UTERINE CERVICITIS; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; VIRUS DIAGNOSIS; VIRUS GENE;

DNA VIRUSES; PAPILLOMAVIRUS;

EID: 0036796858     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1177/002215540205001014     Document Type: Article

References (12)

1. Autillo-Touati A, Joannes M, d'Ercole C, Robaglia-Schlupp A, Lambert A, Mazzella E, Blanc B, et al. (1998) HPV typing by in situ hybridization on cervical cytologic smears with ASCUS. Acta Cytol 42:631-638
2. Lizard G, Demares-Poulet MJ, Roignot P, Gambert P (2001) In situ hybridization detection of single-copy human papillomavirus on isolated cells, using a catalysed signal amplification system: Gen-Point. Diagn Cytopathol 24:112-116
3. Manavi M, Bauer M, Pischinger K, Czerwenka K (2001) Detection of human papillomavirus on Papanicolaou-stained cervical smears using indirect in situ polymerase chain reaction hybridization. Arch Pathol Lab Med 125:353-357
4. Nuovo GJ (2002) Diagnosis of human papillomavirus using in situ hybridization and in situ polymerase chain reaction. Methods Mol Biol 179:113-136
5. Riethmuller D, Gay C, Bertrand X, Bettinger D, Schaal JP, Carbillet JP, Lassabe C, et al. (1999) Genital human papillomavirus infection among women recruited for routine cervical cancer screening or for colposcopy determined by hybrid capture II and polymerase chain reaction. Diagn Mol Pathol 8:157-164
6. Sherman ME, Shiffman MH, Lorincz AT, Herrero R, Hutchinson ML, Bratti C, Zahniser D, et al. (1997) Cervical specimens collected in liquid buffer are suitable for both cytologic screening and ancillary human papillomavirus testing. Cancer 81:89-97
7. Shlay JC, Dunn T, Byers T, Baron AE, Douglas JM (2000) Prediction of cervical intraepithelial neoplasia grade 2-3 using risk assessment and human papillomavirus testing in women with atypia on Papanicolaou smears. Obstet Gynecol 96:410-416
8. Vernon SD, Unger ER, Miller DL, Lee DR, Reeves WC (1997) Association of human papillomavirus type 16 integration in the E2 gene with poor disease-free survival from cervical cancer. Int J Cancer 74:50-56
9. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, et al. (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189:12-19
10. Wick MJ (2000) Diagnosis of human papillomavirus gynecologic infections. Clin Lab Med 20:271-287
11. Wiedorn KH, Kuhl H, Galle J, Caselitz J, Vollmer E (1999) Comparison of in-situ hybridization, direct and indirect in-situ PCR as well as tyramide signal amplification for the detection of HPV. Histochem Cell Biol 111:89-95
12. Zur Hausen H (1999) Immortalization of human cells and their malignant conversion by high risk human papillomavirus genotypes. Semin Cancer Biol 9:405-411